Valeant CEO Pearson Says He's Recovering After Complications

  • Timing of return remains uncertain, Pearson says in memo
  • Pearson was hospitalized last month with severe pneumonia

Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson, who’s been on medical leave of absence since last month, said he’s on the road to recovery after suffering from complications.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.